We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
-3%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$12.9B
AUM Growth
-$678M
Cap. Flow
+$6.37M
Cap. Flow %
0.05%
Top 10 Hldgs %
23.8%
Holding
3,083
New
921
Increased
335
Reduced
1,799
Closed
24

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$60.7M
2
MDT icon
Medtronic
MDT
+$35.8M
3
AAPL icon
Apple
AAPL
+$30.8M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
LIN icon
Linde
LIN
+$24.3M

Sector Composition

Rank Sector Weight
1 Technology 24.64%
2 Financials 13.28%
3 Healthcare 13.15%
4 Consumer Discretionary 12.03%
5 Industrials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGEM icon
2626
Cullinan Oncology
CGEM
$1.01B
$34K ﹤0.01%
+3,207
New +$43.3K
EGAN icon
2627
eGain
EGAN
$187M
$34K ﹤0.01%
+2,905
New +$32.7K
ESPR
2628
DELISTED
Esperion Therapeutics
ESPR
$34K ﹤0.01%
+7,266
New +$31.2K
GNTY
2629
DELISTED
Guaranty Bancshares
GNTY
$34K ﹤0.01%
+966
New +$35.1K
GWRS icon
2630
Global Water Resources
GWRS
$206M
$34K ﹤0.01%
+2,066
New +$32.4K
ITIC
2631
Investors Title Co
ITIC
$546M
$34K ﹤0.01%
+166
New +$33.1K
LAB icon
2632
Standard BioTools
LAB
$340M
$34K ﹤0.01%
9,549
-700
-7% -$2.42K
RCEL icon
2633
Avita Medical
RCEL
$135M
$34K ﹤0.01%
+3,967
New +$36.6K
SPFI icon
2634
South Plains Financial
SPFI
$845M
$34K ﹤0.01%
+1,268
New +$35.9K
SPRO icon
2635
Spero Therapeutics
SPRO
$67.7M
$34K ﹤0.01%
+3,887
New +$39.8K
VERA icon
2636
Vera Therapeutics
VERA
$2.3B
$34K ﹤0.01%
+1,438
New +$30.9K
WCN
2637
Waste Connections
WCN
$42.2B
$34K ﹤0.01%
+242
New +$31K
SPPI
2638
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$34K ﹤0.01%
26,544
-57,707
-68% -$53.1K
ALLK
2639
DELISTED
Allakos
ALLK
$33K ﹤0.01%
+5,793
New +$37.4K
APYX icon
2640
Apyx Medical
APYX
$173M
$33K ﹤0.01%
+5,094
New +$50.2K
BRT
2641
BRT Apartments
BRT
$281M
$33K ﹤0.01%
+1,377
New +$30.9K
CRIS icon
2642
Curis
CRIS
$9.78M
$33K ﹤0.01%
34
-3
-8% -$3.83K
IMVT icon
2643
Immunovant
IMVT
$7.93B
$33K ﹤0.01%
+5,943
New +$37K
PARAA
2644
DELISTED
Paramount Global Class A
PARAA
$33K ﹤0.01%
+808
New +$30.2K
KLRS
2645
Kalaris Therapeutics
KLRS
$83.5M
$33K ﹤0.01%
+209
New +$41.7K
DZSI
2646
DELISTED
DZS Inc. Common Stock
DZSI
$33K ﹤0.01%
+2,369
New +$34.3K
AVDX
2647
DELISTED
AvidXchange
AVDX
$32K ﹤0.01%
+3,964
New +$40K
BRBS icon
2648
Blue Ridge Bankshares
BRBS
$315M
$32K ﹤0.01%
+2,098
New +$35.1K
CCRD
2649
DELISTED
CoreCard
CCRD
$32K ﹤0.01%
+1,184
New +$40.2K
CLPT icon
2650
ClearPoint Neuro
CLPT
$448M
$32K ﹤0.01%
+3,111
New +$28.3K

Similar funds

Amalgamated Bank's Q1 2022 Portfolio in Review

As of Q1 2022, Amalgamated Bank held 3,083 positions worth $12.9B, down 5% from $13.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Amalgamated Bank's Q1 2022 filing shows 921 new, 335 increased, 1,799 reduced and 24 closed positions. Its largest new stake was Accenture: 180,111 shares worth $60.7M. The largest sale was iShares Core S&P 500 ETF, an estimated $21M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Amalgamated Bank's largest Q1 2022 buy was Accenture: 180,111 shares worth $60.7M.
  • Amalgamated Bank added most to Apple in Q1 2022, an estimated $30.8M increase.
  • Amalgamated Bank's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $21M.
  • Amalgamated Bank fully exited iShares Russell 3000 ETF in Q1 2022, selling an estimated $15.3M.
  • Amalgamated Bank's ten largest holdings make up 24% of its $12.9B portfolio in Q1 2022.
  • Amalgamated Bank opened 921 new positions and closed 24 in Q1 2022.
  • Amalgamated Bank's portfolio value fell 5% quarter-over-quarter to $12.9B.

Based on Amalgamated Bank's 13F filing for Q1 2022, filed 30 Jun 2022.